The EHA2023 (European Hematogoly Association) Hybrid Congress took place from June 8th to June 15th, 2023, in Frankfurt, Germany.

This year’s event was primarily an in-person event with virtual broadcasts available.

The program at a glance is available here. With this social media analysis, we will be assessing the impact of the congress online.

Scope

The scope of the analysis is focused on mentions coming worldwide.*

There were a total of 7K mentions recorded during the listening period from June 01st, 2023, to June 25th, 2023 (one week before and two weeks after the conference).

All mentions came from Twitter.

A total of 2K unique authors were identified.

*#eha23 OR #eha2023 OR (eha NEAR/2 (2023 OR 23))

 Methodology

Volume of conversations

Overall volume of mentions was down 17% when compared to last year. Most mentions happened during the congress with a peak on the 9th of June.

Volume of mentions overtime EHA 2023: HCPs

Top hashtags

The top hashtag was #mmsm (multiple myeloma social media).

Also of note, the use of the hashtags #youngeha reserved for junior members of EHA

The official hashtag #eha2023 was the most used one with the variation #eha23 in second place.

Share of Voice (SOV) of medical conditions most discussed

(# of mentions): acute myeloid leukemia, multiple myeloma and myelodysplastic syndromes dominated online discussions

Focus on multiple myeloma

Overall bispecific antibodies elranatamab and talquetamab took center stage online during #eha23 with the results of MagnetisMM-3 being particularly cited.

Driven by the results from CARTITUTE-4 + additional results from CARTITUDE-1, CAR-T therapies were also of high interest with cilta-cel being the most mentioned molecule.

Topics of discussions (type of treatment)

Volume of mentions